Sagility India IPO Sees Strong Retail Demand with 40% Subscription on Day 2: All You Need to Know

Sagility India, a healthcare technology service provider, has witnessed a promising start to its IPO, reaching 40% subscription by Day 2, November 6. This IPO is an offer for sale from the promoters, involving 70.22 crore equity shares valued at approximately ₹2,106.60 crore. The primary objective of the IPO is to enable the listing of the company and facilitate a partial exit for the promoters.

As per NSE data, nearly 14 crore bids were placed against the 38.7 crore shares available, indicating strong interest from various investor categories. Retail individual investors (RIIs) demonstrated particularly high enthusiasm, oversubscribing their portion almost twice over. Non-institutional investors (NIIs), however, subscribed to only 13% of their allocated shares, while qualified institutional buyers (QIBs) placed bids for around 49,000 of the 21 crore shares available. The category reserved for employees also recorded a high subscription rate, exceeding twice the allotted shares.

The Sagility India IPO, with a price range set at ₹28 to ₹30 per share, requires a minimum investment of ₹15,000 for 500 shares. The subscription window, which opened on November 5, will close on November 7. Following the close, the IPO listing on the BSE and NSE is anticipated for November 12. This offering attracted notable anchor investors who committed ₹945 crore on November 4, providing early momentum and signalling institutional interest in the company's future.

Sagility India, previously known as Berkmeer India Private Limited, specializes in delivering healthcare solutions for U.S.-based insurers and healthcare service providers. This strategic focus positions the company as a critical player in the technology-enabled healthcare services industry, particularly given the rising demand for cost-effective and quality healthcare solutions in the United States.

Several key financial firms are leading the IPO process. ICICI Securities, IIFL Securities, Jefferies India, and J.P. Morgan India are the appointed lead managers, with Link Intime India providing registry services. The listing is expected to bolster Sagility India’s visibility and allow investors in India to participate in the growth of this healthcare solutions provider.

ALSO READ| How Rs 10,000 Turned into Rs 67 Crore: Elcid Investments' Record-Breaking Stock Surge Explained

For investors, this IPO offers an opportunity to invest in a healthcare-focused technology company with an established market presence and client base in the United States. While retail demand appears strong, potential investors should consider their risk appetite given that stock market investments are inherently volatile.

[Disclaimer: Investing in the securities market carries market risks, and past performance is not indicative of future results. Please consider seeking financial advice before making any investment decisions].